港股科技50ETF(513980)涨近2%，成交额超5亿元！依然看好港股相对全球市场的收益表现

Group 1 - The core viewpoint of the articles highlights a positive trend in the Hong Kong stock market, particularly in technology and pharmaceutical sectors, with significant gains observed in the Hong Kong Technology 50 ETF and various individual stocks [1][2] - The Hong Kong Technology 50 ETF (513980) has seen a year-to-date increase of over 32%, with a recent trading volume of 5.07 billion yuan and a net inflow of 62.05 billion yuan since the beginning of the year [1] - Major stocks in the innovation drug sector have shown strong performance, with notable increases such as Genscript Biotech rising over 14% and 3SBio increasing over 7% [1] Group 2 - According to Huatai Securities, the recent positive signals from the US-China summit may reduce tariff friction, potentially enhancing China's growth expectations and providing upward momentum for the renminbi and its assets [1] - Industrial growth is anticipated to focus on technology, particularly the AI industry chain, with an emphasis on upstream computing power and downstream application innovation [2] - The Hong Kong Technology 50 ETF is the largest in its category, with a fund size of 135.99 billion yuan, reflecting the performance of leading companies in internet, new energy vehicles, and biomedicine sectors [2]